Serum alkaline phosphatase elevation as a preoperative sarcopenic biomarker in digestive cancer: a retrospective cohort study

  • 0Department of Rehabilitation Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. uncle_harry.7@outlook.com.

Summary

This summary is machine-generated.

Elevated serum alkaline phosphatase (ALP) may indicate sarcopenia risk in preoperative digestive cancer patients. This chronic inflammation marker could help identify patients needing intervention before surgery.

Area Of Science

  • Oncology
  • Gastroenterology
  • Geriatrics
  • Biochemistry

Background

  • Sarcopenia is linked to poor prognosis and postsurgical complications in preoperative patients.
  • The mechanism of sarcopenia in cancer patients is not fully understood.
  • Chronic inflammation is implicated in sarcopenia development.

Purpose Of The Study

  • To investigate if elevated serum alkaline phosphatase (ALP) can serve as a preoperative sarcopenia marker in patients with digestive cancer.
  • To explore the association between chronic inflammation, indicated by ALP, and sarcopenia in this patient group.

Main Methods

  • Retrospective analysis of electronic medical records from 274 patients with digestive cancer.
  • Patients were categorized into sarcopenia (SC) and nonsarcopenia (NSC) groups based on perioperative screening.
  • Statistical analysis was performed, accounting for confounders like age, liver function, and bone fractures.

Main Results

  • Serum ALP levels were significantly higher in the sarcopenia group (168.4 U/L) compared to the nonsarcopenia group (100.4 U/L).
  • Elevated ALP showed a significant correlation with sarcopenia risk (p=0.0018, OR=1.0055).
  • Significant differences were observed in albumin, hemoglobin, neutrophil-to-lymphocyte ratio, and malnutrition parameters between groups.

Conclusions

  • Serum ALP elevation, potentially due to chronic inflammation, is correlated with sarcopenia in preoperative digestive cancer patients.
  • ALP may serve as a useful biomarker for identifying sarcopenia risk in this population.